Summary:
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia.
Qualified Participants Must:
• Be 18 years or age or older
•
Have widespread pain present for at least 3 months
•
Be able to undergo pre-study washout of prohibited concomitant medications
•
More Inclusion/Exclusion criteria apply
Qualified Participants May Receive:
Compensation for time and travel as well as receive study-related exams, labs, office visits at no cost to you.